Home Your basket
• Psychosocial quality of l...
   Price 10.50 €
• Hearing aid : practical a...
   Price 10.50 €
• Evaluation of a dysphonic...
   Price 10.50 €
• Otomycosis...
   Price 10.50 €
• The effectiveness of voic...
   Price 14.00 €
• CT scanning in "second lo...
   Price 5.50 €
• Central auditory processi...
   Price 10.50 €
• Pott’s puffy tumour, rare...
   Price 8.50 €
• Hyperglycemia after intra...
   Price 8.50 €
• Treatment of severe epist...
   Price 5.50 €
• Otomycosis: Clinical and ...
   Price 5.50 €
• Positioning in the oropha...
   Price 8.50 €
• Newborn and infant nasal ...
   Price 5.50 €
• Distortion product otoaco...
   Price 10.50 €
• Botulinum toxin and rejuv...
   Price 10.50 €
• Revision ossiculoplasty: ...
   Price 10.50 €
• Polymorphisms of the huma...
   Price 10.50 €
• Phonatory threshold press...
   Price 10.50 €
• Treatment failures in ben...
   Price 10.50 €
• Pure sensorineural hearin...
   Price 5.50 €
• Proposal of a rating scal...
   Price 10.50 €
• Arachnoid granulations of...
   Price 10.50 €
• Contribution of endoscopi...
   Price 8.50 €
• Facial dissection applied...
   Price 14.00 €
• Develop­ment of an osteos...
   Price 8.50 €
• Lateral semicircular cana...
   Price 10.50 €
• Reconstruction after tumo...
   Price 10.50 €
• Laryngeal schwannomas...
   Price 5.50 €
• Transverse maxillary defi...
   Price 8.50 €
• Sinonasal hemangiopericyt...
   Price 5.50 €
• BAHA in single sided deaf...
   Price 12.50 €
• Chronitis tonsillitis...
   Price 8.50 €
• Implication of mitochondr...
   Price 10.50 €
• Free sorting task of spee...
   Price 10.50 €
• What we don’t know about ...
   Price 12.50 €
• Interstitial brachytherap...
   Price 8.50 €

Total Order 338.00 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 2 - 2003 o

RHINOLOGY

Nasal polyposis: long term functional results in 203 patients treated by ethmoïdectomy associated with intranasal corticotherapy.


Authors : M. Folia, L. Lombard, S. Vergès, J. Percodani, J. J. Pessey, E. Serrano (Toulouse)

Ref. : Rev Laryngol Otol Rhinol. 2003;124,2:105-110.

Article published in french
Downloadable PDF document french



Summary : Objective: Evaluate the long term quality of life in patients after ethmoidectomy associated with intranasal corticotherapy for nasal polyposis on the appreciation of the intensity of nasal symptoms. Material et method: The authors report their experience about 203 patients treated by endonasal endoscopic ethmoïdectomy intranasal followed by a long term intranasal corticotherapy, with a mean follow up of six years. In this prospective study, each symptom was evaluated using an analogic visual scale and a questionnaire. The evolution of asthma after surgery and the patients global satisfactory rate were noted. Results: there is a global improvement of the nasal symptoms with a mean postoperative individual scores calculated at 32% for nasal obstruction, at 34% for rhinorrhea and at 51% for anosmia. No impact on asthma or improvement of asthma was encountered in 92% of the patients. The patients global satisfactory rate of this medico-surgical approach of the disease is 93.6%. A positive correlation was found between the severity of the olfactory disorders and the oral corticosteroid therapy. Conclusion: Endoscopic endonasal ethmoïdectomy followed by intranasal corticotherapy represents a valuable protocol in treating patients with severe nasal polyposis.

Price : 10.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE